ICICI Lombard Q2 FY26 profit up 18%: 10 key facts

Stock in focus on earnings and broker calls

ICICI Lombard General Insurance Company Ltd remained in focus around April 15, 2026, with earnings expected on 15/04/2026 and multiple brokerage notes circulating. The stock was quoted around ₹1,858 to ₹1,859 in the late afternoon session, up about 4.2% on the day. The day’s trading range was ₹1,795 to ₹1,865.70, while the 52-week range stood at ₹1,629.50 to ₹2,068.70. Reported volume was about 1.40 million shares. A “score” of 58/100 was shown alongside the stock snapshot.

Q2 FY26 headline: net profit rises 18%, stock jumps

The sharpest near-term trigger cited in the material was the company’s Q2 FY26 performance, where ICICI Lombard reported an 18% year-on-year rise in net profit to ₹820 crore versus ₹694 crore a year ago. The stock rose nearly 8% on the session following the results and touched a three-month high of ₹2,002.20. Trading volume was described as nearly five times the 10-day average, marking the best session since May 2023.

Premium trend: GDPI declines, but mix matters

While profit improved, the quarter also saw a weaker top-line premium growth picture in the reported GDPI number. Gross Direct Premium Income (GDPI) for the quarter was ₹6,596 crore, down 1.9% year-on-year, while the industry recorded 5.9% growth. Excluding crop and mass health, ICICI Lombard’s GDPI rose 3.5% compared with industry growth of 9.8%. The company reaffirmed a return on equity (ROE) target of 18% to 20%.

Interim dividend raised

Alongside the results, ICICI Lombard declared an interim dividend of ₹6.50 per share, compared with ₹5.50 last year. The higher payout was presented as part of the quarterly update, coming at a time when profitability was supported by both operating and investment factors.

What the earnings review highlighted

A SEBI-registered analyst, Finkhoz, flagged three operating datapoints from the quarter. Profit after tax (PAT) increased 18% year-on-year. Operating profit increased to ₹1,044 crore from ₹940 crore. Revenue rose 11.7% year-on-year to ₹6,869 crore. The same note stated that motor loss ratios (65% to 67%) and retail health loss ratios (65% to 70%) remained “healthy”, while crediting tight cost control and disciplined underwriting.

Brokerages: targets cluster around ₹2,000 to ₹2,250

Broker views in the supplied text were mixed, with several “buy” ratings but also valuation caution. HSBC maintained a ‘Buy’ rating with a target of ₹2,250, implying more than 21% upside from the referenced last close. Morgan Stanley kept an ‘Equal-Weight’ rating with a ₹2,035 target, noting profits were boosted by investment income while underwriting results remained subdued, and adding that valuations were not cheap.

Separately, ICICI Securities issued a ‘Buy’ call on March 16, 2026 with a target price of ₹2,250, and framed its thesis around multi-year earnings compounding and expectations of improving loss ratios. That report cited earnings growth of 25.4% between FY22 to FY25 and 11.3% year-on-year growth in 9MFY26 (7.5% excluding capital gains), with a five-year earnings CAGR of 16%. It also pegged valuation at 28x FY28E EPS of ₹79.4.

Analyst consensus snapshot from market intelligence

A separate analyst-consensus snapshot (S&P Global Market Intelligence, based on 26 analysts) showed 61.54% ‘Buy’, 30.77% ‘Hold’ and 7.69% ‘Sell’. The average target price was ₹2,107.12, with a high of ₹2,400 and a low of ₹1,450. The snapshot also referenced a current price of ₹1,921.3, implying an upside of 9.67% to the average target.

Key numbers at a glance

Other reported financial and valuation datapoints

A company snapshot also listed market capitalization at ₹98,836 crore, dividend yield (indicated) of 0.68%, P/E (TTM) of 35.50, and basic EPS (TTM) of ₹56.45. Net income (FY) was shown as ₹2,508 crore. Separately, a standalone update said December 2025 net sales were ₹6,904.74 crore, up 12.07% year-on-year.

Market impact and what investors tracked

The immediate market impact described in the text was a sharp post-results price move and a jump in traded volumes. Investors also tracked the push and pull between underwriting performance and investment income, as highlighted by Morgan Stanley’s note that underwriting remained subdued even as investment income supported profits. Technical commentary in the feed pointed to a breakout post earnings, with the stock at a resistance band of ₹2,000 to ₹2,100 and an RSI reading of 58.

Risks and watchpoints cited by research notes

The ICICI Securities note explicitly listed risks: increased competitive intensity, a rise in health claims, and lower-than-expected industry growth. Another feed item also framed ICICI Lombard’s profitability as being under pressure in a competitive insurance market. Earlier commentary in the compiled text also mentioned sectoral challenges such as lower motor growth and higher loss ratios, though it added that the “worst” may be past and expected improvement in motor and health.

Conclusion

ICICI Lombard’s Q2 FY26 print combined higher profit, a dividend increase, and heavy volumes that pushed the stock to a three-month high, even as reported GDPI declined year-on-year. The next set of cues in the provided material is the scheduled earnings event on April 15, 2026 and how premium growth and underwriting trends evolve relative to peers and industry growth.